Germany digital PCR (dPCR) and real-time PCR (qPCR) market is expected to grow at a CAGR of 8.0% during the forecast period. Germany is one of the major destinations for pharmaceutical R&D across the globe. As per the European Federation of Pharmaceutical Industries and Associations (EFPIA), the country invested nearly $8.3 billion in pharmaceutical R&D in 2017. This growth in pharma R&D results in the growing number of drug discovery and development, which in turn, is leading the demand for dPCR and qPCR technology in the country. The major life sciences firms operating in Germany include Merck KGaA and Eppendorf AG. These companies are developing software and products for the dPCR and qPCR market, to drive the innovation in drug discovery and development process, which in turn, is supporting the growth of the market in Europe. Along with this, the prevalence of cancer has been increasing significantly in Germany, this is expected to be one of the prime reasons which are promoting the growth of the market. 

Further, the growth in the country is also attributed to the presence of large players, such as Eppendorf AG, Merck KGaA, Siemens AG, and many others in the country. These are the key companies adopting various strategies such as new product launches and approvals, merger and acquisition, partnerships and collaborations, and many others to thrive in a competitive environment. For instance, in March 2018 Fast Track Diagnostics (FTD), a subsidiary of Siemens Healthineers launched human papillomavirus (HPV) tests and expanded the STD portfolio. Under the test, the company offers a CE-labelled, real-time PCR kit for the detection of 14 HPV High-Risk subtypes.

Research Methodology

The market study of the Germany dPCR and qPCR market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings authenticity in our reports.

Secondary Sources Include:

• Financial reports of companies involved in the market
• Whitepapers, research-papers, and news blogs
• Company websites and their product catalog

The report provides an in-depth analysis of pricing, market size, intended quality of the product preferred by consumers. It will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.

Market Segmentation:

1. Germany dPCR and qPCR Market Research and Analysis, By Technology
2. Germany dPCR and qPCR Market Research and Analysis, By Product
3. Germany dPCR and qPCR Market Research and Analysis, By Application

The Report covers:

• Comprehensive research methodology of the Germany dPCR and qPCR market.
• This report also includes a detailed and extensive market overview with key analyst insights.
• Exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
• Analysis of regional regulations and other government policies impacting the Germany dPCR and qPCR market.
• Insights about market determinants which are stimulating the Germany dPCR and qPCR market.
• Detailed and extensive market segments with regional distribution of forecast revenues.
• Extensive profiles and recent developments of market players.